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Muscle growth during embryogenesis is the result of a balance between the proliferation of myoblasts and their differentia-
tion into mature, contractile ®bers. Fibroblast growth factors (FGFs) are potent stimulators of myoblast proliferation and
inhibitors of myoblast differentiation in vitro. However, it is not clear at present if FGFs and their receptors regulate this
process in vivo, partially because no FGF receptor was known to be expressed by myoblasts during embryogenesis. In this
study, we have used quail/chick grafting and BrdU labeling techniques to demonstrate that a recently cloned avian FGF
receptor, FREK, is expressed by replicating skeletal muscle myoblasts, while differentiated muscle cells no longer express
this receptor. In the limb, muscle progenitors originating from the somite start expressing FREK at 3 days of development
(E3). FREK expression in the limb myoblasts follows that of Pax-3 and Pax-7, but precedes that of MyoD. Since MyoD
expression signals the onset of terminal differentiation, this demonstrates that FREK is expressed in muscle progenitors
prior to overt muscle differentiation. A more complex situation is observed in the trunk region, where a ®rst wave of
MyoD-positive myocytes, which are postmitotic and never express FREK, appear in the early myotomal compartment of
the somite. Slightly later, at E2.5, FREK-positive myoblasts migrate into the myotome as a second wave of muscle progeni-
tors, 15 hr after the ®rst MyoD-positive cells. FREK's expression by myoblasts arising at all stages of myogenesis indicates
that this growth factor receptor represents one of the earliest molecular markers for this cell population. FREK's prominent
expression during muscle differentiation sets it apart from other FGF receptors and suggests that this molecule plays an
important role during muscle growth and differentiation. q 1995 Academic Press, Inc.
INTRODUCTION and Klein, 1994). In muscle cell lines, FGF directly represses
myogenesis: the binding of the ligand to its receptor triggers
a signaling pathway which ultimately leads to the phos-Myogenesis is the stepwise process whereby undifferenti-
phorylation and inactivation of myogenic determinationated multipotent mesodermal cells differentiate into a
factors of the MyoD family (Li et al., 1992). Although FGFshighly specialized contractile muscle ®ber. Muscle growth
are expressed at appropriate times and places to play a roleduring embryogenesis and postnatal life is the result of a
in the regulation of myogenesis during development (Jo-balance between the proliferation of myogenically compe-
seph-Silverstein et al., 1989; Dono and Zeller, 1994; Masontent myoblasts present in the muscle masses and their dif-
et al., 1994; Savage et al., 1993; Niswander and Martin,ferentiation into mature muscle ®bers. In vivo, the signals
1992; deLapeyriere et al., 1993; Han and Martin, 1993), littlethat induce myogenesis remain unknown. However, when
is known regarding their function in vivo.placed in tissue culture, the differentiation of skeletal my-
The biological activities of FGFs are mediated by bindingoblasts is inhibited by exogenous peptide growth factors
to tyrosine kinase receptors. In vitro studies have shownthat prevent entry into the differentiation pathway. One of
that the differentiation of muscle cell lines is accompaniedthe most potent inhibitors of myoblast differentiation in
by the disappearance of FGF receptors (FGFR) from the cellvitro is ®broblast growth factor (FGF; Gospodarowicz et al.,
surface. In a mouse skeletal muscle cell line, MM14, it was1976; Clegg et al., 1987; reviewed in Olson, 1992; Olson
further demonstrated that FGFR1 transcription is greatly
reduced upon differentiation, suggesting that FGFR1 medi-
ates the FGF-dependent differentiation of this line (Olwin1 To whom correspondence should be addressed. Fax: (714) 824-
4709. and Hauschka, 1988; Templeton and Hauschka, 1992). In
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vivo, FGFR1 is highly expressed in most embryonic tissues, breeder and incubated at 387C in a humid atmosphere until
they reached the desired embryonic stage, determined ac-but appears to be absent from the early avian or mammalian
myotome (Orr-Urtreger et al., 1991; Peters et al., 1992; Ya- cording to the criteria of Hamburger and Hamilton (1951).
maguchi et al., 1992; our observation). Therefore, it is un-
clear if FGFR1 plays a speci®c role during early myoblast
cDNA Probesdifferentiation. In the mouse, FGFR4 is the only FGF recep-
tor expressed in embryonic skeletal muscle (Stark et al., To determine FREK expression patterns, a 460-bp PstI±
1991; Korhonen et al., 1992). However, its function during EcoRI FREK cDNA fragment encompassing the 3 * half of
muscle differentiation has yet to be investigated. the third Ig-like domain, the transmembrane domain, and
We have recently isolated a novel avian FGF receptor, the entire juxtamembrane domain (Marcelle et al., 1994)
named FREK, whose structure and pattern of expression was cloned into pGEM3z vector (Promega) and used to pre-
are distinct from other cloned FGF receptors, including the pare antisense and sense FREK-speci®c RNA probes. This
mammalian FGFR4 (Marcelle et al., 1994). During avian quail probe detects mRNA transcripts in chick tissues as
development, the expression pattern of FREK is compatible well (our observation). To determine MyoD expression, we
with a possible function in skeletal muscle differentiation, prepared antisense RNA probes from the complete 1518-bp
since it is expressed in the myotome and later in develop- chick MyoD cDNA inserted into pBluescript (Lin et al.,
ment in all embryonic skeletal muscles. Furthermore, its 1989; kindly provided by Dr. B. Paterson). Pax-3 and Pax-7
expression decreases during muscle differentiation. In cell 660-bp cDNA clones (isolated by Dr. M. Goulding and
culture, we previously demonstrated that: (1) FREK is ex- kindly provided by Dr. P. Gruss) were used to determine
pressed by satellite cells, which are myoblasts present in Pax expression. Both clones encompass the homeodomain
the adult chick muscle; (2) FREK transcription is decreased and the paired boxed domains.
by retinoic acid, which induces satellite cell differentiation;
and (3) addition of FGF2, which induces proliferation of
satellite cells, causes a rapid increase in FREK transcript In Situ Hybridization
(Marcelle and Eichmann, 1992; Marcelle et al., 1994; Halevy
For radioactive in situ hybridization, quail or chick em-et al., 1994). These characteristics suggest that FREK is a
bryos were ®xed in 4% paraformaldehyde/phosphate-buf-good candidate for mediating some of the activities of FGF-
fered saline (PBS), embedded in paraf®n, and sectioned at alike molecules on avian muscle myoblasts both in vivo and
thickness of 5 mm. The procedures applied for treatment ofin vitro. The goal of the present study was to characterize
sections, hybridization, and washing were those of Waka-the nature, distribution, and origin of FREK-expressing cells
matsu and Kondoh (1990), modi®ed as already describedin the developing somites and limbs of the early chick em-
(Eichmann et al., 1993) with the exception that sectionsbryo to help elucidate its function in muscle development.
were transferred and processed onto Superfrost/Plus slides
(FisherScienti®c). Exposure times were 10 days for the FREK
probe and 3 days for the MyoD, Pax-3, and Pax-7 probes.MATERIALS AND METHODS
Nonisotopic in situ hybridization was performed on cryo-
stat sections as described previously (StraÈhle et al., 1994)Embryonic Material
with the following modi®cations: embryos were ®xed over-
night at 47C in 4% paraformaldehyde/PBS. After a wash inExperiments were performed on quail (Coturnix coturnix
japonica) or White Leghorn chicken (Gallus gallus) em- PBS, embryos were immersed for a few hours in 30% su-
crose/PBS at 47C. They were then embedded in Tissue-Tekbryos. Fertilized eggs were purchased from a commercial
FIG. 1. FREK is expressed by mononucleated, replicating cells present in the skeletal muscles. (A and B) Longitudinal sections of pectoral
muscle were ®rst hybridized with a FREK nonisotopic RNA probe (A) and then reacted with the anti-muscle monoclonal antibody 13F4
(B). FREK-positive cells (in blue, A) appear interspersed along the muscle ®bers, recognized by the 13F4 antibody (in green, B). Arrows
indicate that FREK-positive cells are 13F4-negative. (C and D) A 6-day-old embryo was exposed for 2 hr to BrdU. Sections at the forelimb
level were sequentially hybridized to a FREK nonisotopic RNA probe (C) and reacted with an anti BrdU monoclonal antibody (D). In a
transverse section through a shoulder muscle, arrows show that in many instances FREK expression colocalizes with BrdU-positive nuclei,
indicating that FREK-positive cells have undergone DNA synthesis while being exposed to BrdU.
FIG. 2. FREK-positive cells in the limb belong to the skeletal muscle lineage. (A) A portion of the segmental plate and the two most
recently formed somites (in white) of a 15-somite chick embryo (stage 11 ±12) were removed and replaced by an equivalent portion of a
quail paraxial mesoderm (shaded). Four days later, sections through the forelimb of the embryo were sequentially analyzed for FREK
expression (B and D) and for the presence of quail cells, recognized by the QCPN monoclonal antibody (C). Both muscle masses present
at that stage of development display high FREK expression (B). Enlargement of a portion of this ®gure (D corresponds to boxed area in B)
shows that FREK-positive cells (arrows in D) are of quail origin (arrows in C), indicating that FREK-positive cells originated from the
grafted material. Arrowhead in C and D indicates an endothelial cell of quail origin. Ca, cartilage.
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O.C.T. compound (Miles Inc.) and sectioned. Ten-microme- contain a heterogeneous array of cell types including multi-
nucleated muscle ®bers, myoblasts, mesenchymal cells, ®-ter sections were transferred to Superfrost/Plus slides and
processed as described (StraÈhle et al., 1994). broblasts, endothelial cells, and macrophages. To determine
which of the cell components of the muscle are expressing
FREK, cryostat sections were made through the trunk re-Antibody Staining, Microscopy
gion of 9-day-old quail embryos and hybridized with a non-The following antibodies were used for staining sections:
isotopic FREK probe. In longitudinal sections of pectoral13F4 monoclonal antibody, speci®c for chick skeletal mus-
muscle, long muscle ®bers are obvious both by Nomarskicle cells (N. Le Douarin and P.M. Rong); MF20 monoclonal
differential interference contrast microscopy (Fig. 1A) andantibody speci®c for chick embryonic myosin heavy chain
with the muscle-speci®c 13F4 monoclonal antibody (Fig.(D. Fishman); and QCPN monoclonal antibody speci®c for
1B). All FREK-positive cells appeared to be mononucleatedquail cells (B.M. Carlson and J.A. Carlson; all three were
single cells (Fig. 1A) interspersed along the muscle ®bers.obtained from the Developmental Studies Hybridoma Bank
A comparison of Figs. 1A and 1B shows that FREK-positivemaintained by the Department of Pharmacology and Molec-
cells do not express the 13F4 antigen, indicating that FREKular Sciences, The John Hopkins University School of Medi-
is not expressed by differentiated muscle cells. This distri-cine, Baltimore, MD 21205 and the Department of Biology,
bution pattern was not unique to pectoral muscle but wasUniversity of Iowa, Iowa City, IA 52242 under contract
observed in all examined skeletal muscles of the embryoN01-HD-2-3144 from the NICHD). After in situ hybridiza-
(i.e., head, trunk, and limb skeletal muscles, data nottion with nonisotopic probes visualized with NBT±BCIP
shown).substrate, sections were washed in PBS and incubated with
The morphology of FREK-positive cells as mononucleatedthe monoclonal antibody supernatant overnight at 47C.
cells along muscle ®bers is reminiscent of satellite cellsAfter washing in PBS, FITC-coupled secondary antibody
observed along adult muscle ®bers. Satellite cells are the(goat anti-mouse HI FITC, Antibodies Inc., Davis, CA) di-
only undifferentiated cells of adult skeletal muscle that areluted 1:200 in PBS/1%BSA was applied on sections for 1 hr.
capable of cell division and differentiation into new muscleSlides were viewed with a Zeiss Axiophot epi¯uorescence
®bers (reviewed in Manzanet and Franzini-Armstrong,microscope. Data were recorded photographically or using a
1986). To test whether these FREK-positive cells were capa-Hamamatsu SIT camera and stored on removable Bernouilli
ble of cell division, embryos at 3, 4, 6, and 9 days of develop-discs. Image processing was accomplished using the Vidim
ment were incubated for 2 hr with the deoxynucleotidesoftware system (Fraser, Stolberg, and Belford, unpublished).
analog BrdU. After ®xation of the embryos, cryostat sec-
tions were sequentially hybridized with a FREK RNA probeEmbryonic Surgery
and stained with an anti-BrdU antibody. At all embryonic
Chicken eggs were windowed at stages 11±12 (Ham- stages, cells containing both FREK and BrdU signals were
burger and Hamilton, 1951). India ink Pelikan fount diluted observed. Figures 1C and 1D show a section at the forelimb
1:10 in PBS was injected below the embryo to improve its level of a 6-day-old embryo in which many FREK-positive
visualization and the vitelline membrane was removed. The cells are labelled with the BrdU antibody. Lengthening the
chick somitic mesoderm (somites and/or segmental plate) exposure of the embryo to BrdU increases the number of
contributing to the formation of the wing muscles (somites FREK/BrdU-positive cells (not shown), indicating that most
13±20, Chevallier et al., 1977; Christ et al., 1977; Ordahl, if not all FREK-expressing cells are actively replicating in
personal communication) was dissected from the embryo the embryo.
and replaced by quail mesoderm of similar size, level, and Finally, to determine whether FREK-positive cells present
stage. Glass microneedles were used to remove the ecto- in the muscle masses belong to the muscle lineage, we per-
derm and the underlying somites and/or segmental plate on formed quail-chick grafting experiments. As noted above,
one side of the chick embryo. The corresponding quail graft FREK-positive cells are present in all skeletal muscles of
was dissected from the quail, the endoderm was gently the developing embryo, including the limb. Previous studies
scraped off, and the graft with its overlying ectoderm was have shown that the somites contribute to the muscles of
inserted in place of the host mesoderm and ectoderm. We the limb while mesenchymal and cartilage cells of the limb
did not use enzymatic digestion of the host or graft tissues originate from the lateral plate mesoderm (Christ et al.,
to facilitate the grafting procedure. The eggs were then re- 1974, 1977; Chevallier et al., 1977). Thus, by replacing para-
sealed with tape and incubated to stage 28 (E6), when em- xial mesoderm corresponding to presumptive somites 13±
bryos were ®xed and processed for in situ hybridization. 20 of stage 11 chick with an equivalent portion of quail
paraxial mesoderm (Fig. 2A), the myoblasts and muscle cells
in the resultant limb are of quail origin whereas the mesen-RESULTS
chymal and cartilage tissues are of chick origin. Four days
FREK Is Expressed by Replicating Myoblasts of the after grafting (i.e., E6), embryos were analyzed sequentially
Skeletal Muscle Lineage for FREK expression and for the presence of quail cells.
Figure 2B shows that the chimeric forelimb displays a nor-Although FREK expression was detected in developing
and mature muscle (Marcelle et al., 1994), skeletal muscles mal overall structure, with strong FREK expression in the
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two muscle masses present in the limb at this stage of devel- 1994), the 13F4 antigen, and the embryonic myosin heavy
chain recognized by the MF20 antibody. In contrast, noopment. Enlargement of a portion of this ®gure demon-
strates that FREK-positive cells present in the muscle FREK-expressing cells are observed in the newly formed
myotome. FREK-positive cells ®rst appear at stage 17, withmasses are of quail origin, con®rming that they originated
from the grafted quail paraxial mesoderm (Figs. 2C and 2D). faint expression observed at the cervical level in the lateral
part of the dermomyotome and in the myotome (Fig. 3A).This experiment demonstrates that FREK is transcribed in
the limb muscle masses by cells of the skeletal muscle FREK expression in the dermomyotome and the myotome
occurs just before dermis formation, which is ®rst observedlineage.
As reported earlier, FREK is also faintly expressed in pre- at the cervical level of a stage 18 embryo and progresses
caudally with embryonic development (K. Tosney, personalcartilagenous cells, which are of chick origin (not shown).
Figures 2C and 2D show that endothelial cells originating communication, our observation). Dermis formation is
characterized by a ``de-epithelialization'' of the dermomyo-from the grafted material are present in the limb. As the
somites and the tissue immediately ventral to them contain tome, during which cells delaminate and migrate beneath
the ectoderm, where they later participate in the formationendothelial cell precursors, we cannot determine if endothe-
lial cells present in the limb originated from the paraxial of the dermis.
The appearance of FREK-positive cells in the myotomemesoderm or from contaminating tissues in the graft.
Together, these results clearly show that FREK is ex- occurs approximately 15 hr after that of the ®rst myotomal,
MyoD-positive cells. At stage 21, FREK-positive cells arepressed by mononucleated, replicating cells of the skeletal
muscle lineage, properties that describe myoblasts. When observed along the ventral part of the myotome, recogniz-
able by its expression of the embryonic form of the myosinmyoblasts have differentiated into mature muscle ®bers,
they no longer express this receptor. Therefore, FREK is a heavy chain recognized by the MF20 antibody (Figs. 3B and
3C). Similar to the 13F4 muscle marker (Figs. 1A and 1B),marker for a population of replicating avian skeletal muscle
myoblasts. MF20 staining does not colocalize at the cellular level with
FREK. FREK-positive cells do not remain restricted to the
ventral edge of the myotome with subsequent muscle devel-FREK Expression during Myotome Formation opment. As embryonic age progresses and axial muscles
Determines a Second Wave of Myoblast Migration grow in size, FREK-positive cells gradually mix with the
myotomal cells.The somites differentiate ventrally into the sclerotome
and dorsolaterally into the dermomyotome, which subse- These data show that FREK is not only expressed at later
embryonic stages by a population of myoblasts, but also atquently gives rise to the myotome, the migratory limb mus-
cle progenitors, and the dermis. Development proceeds in earlier stages by myoblasts or their precursors. These ®rst
appear in the lateral part of the dermomyotome at arounda rostrocaudal sequence, with the most recently formed so-
mite being an epithelial structure and progressively more stage 17 and are found at the ventral part of the myotome
at stage 21. It is likely that FREK-expressing cells migraterostral somites displaying a more developed myotome.
Myotome formation begins at stage V or VI of somite forma- from the lateral edge of the dermomyotome to the ventral
part of the myotome. This migration represents a secondarytion (corresponding to the level of the ®fth or sixth most
recently formed somite). At this time, dermomyotome cells wave of myotomal muscle precursors that arises about 15
hr after the ®rst wave of MyoD-positive, MF20-positive,ingress to form a second layer of differentiated, postmitotic
muscle cells beneath the dermomyotome, called the myo- postmitotic myocytes. At later stages of development (at
least E6, the last stage at which we compared MyoD andtome (Kaehn et al., 1988; reviewed in Ordahl, 1993).
Myotomal cells express the myogenic determination fac- FREK expression), MyoD expression parallels that of FREK
in all muscles of the trunk region. This and the demonstra-tor MyoD (Williams and Ordahl, 1994; Goulding et al.,
FIG. 3. FREK is expressed at early stages of somite differentiation. (A) Sections of a 29-somite embryo (stage 17) were hybridized to
isotopic FREK RNA probe. At the cervical level of the embryo, FREK expression is detected in the lateral portion of the dermomyotome
and in the myotome. This image was obtained through processing of superposed bright-®eld and dark-®eld images. (B and C) Cryosections
of a stage 21 embryo were sequentially hybridized to a FREK nonisotopic RNA probe (B) and reacted with an anti-embryonic myosin
heavy chain antibody (MF20), which recognizes differentiated myocytes (C). FREK-positive cells (in blue) are located along the ventral
edge of the myotome (in green). Arrows indicate the position of FREK-positive cells in B and C. They show that FREK-positive cells are
MF20-negative. D, dermomyotome; M, myotome; NT, neural tube.
FIG. 4. Expressions of FREK, MyoD, Pax-3, and Pax-7 at the forelimb level of a stage 18 chick embryo. Near-adjacent sections made at
the forelimb level were hybridized to FREK (A), MyoD (B), Pax-3 (C), and Pax-7 (D) isotopic RNA probes. FREK is faintly expressed in the
myotome (M) and in the lateral part of the dermomyotome (D), while it is not expressed in the limb (L). MyoD is restricted to the
myotome. Pax-3 and Pax-7 are expressed in the neural tube (NT) in the dermomyotome and by myogenic precursors migrating in the
limb bud (arrowheads). Arrows indicate the position of the dermomyotome and the myotome. Images were obtained by superposing a
pseudo bright-®eld image taken under uv light and a dark-®eld image.
Copyright q 1995 by Academic Press, Inc. All rights of reproduction in any form reserved.
/ m3586$7991 10-06-95 18:30:16 dba Dev Bio
106 Marcelle, Wolf, and Bronner-Fraser
107FREK in Myoblasts
108 Marcelle, Wolf, and Bronner-Fraser
tion presented below that muscle progenitors of the limb in all skeletal muscle masses. At this stage, MyoD expres-
sion is high and its ®eld of expression parallels that of FREK,sequentially express FREK, and then MyoD, suggest that
FREK-positive cells in the trunk region differentiate to ex- while Pax-3 and Pax-7 expressions are greatly reduced (data
not shown).press MyoD.
In agreement with previous studies (Goulding et al.,
1994; Williams and Ordahl, 1994; Bober et al., 1994), we
In the Limb, FREK Follows Pax-3 and Pax-7 noted that Pax-3 and Pax-7 are expressed throughout the
Expression but Precedes MyoD dermomyotome and in the dorsal part of the neural tube
at stages 18 through 23. Pax-3 expression is highest in theHaving identi®ed a wave of myoblasts (or their precur-
sors) which contributes to the formation of axial muscles, medial and lateral portions of the dermomyotome, while
Pax-7 is more uniformly expressed throughout the dermo-we then investigated FREK expression during limb muscle
formation. Muscle precursors originating from the somite myotome (Williams and Ordahl, 1994). At stage 23, Pax-
3, but not Pax-7, is expressed at the periphery of the dorsalinitiate migration to the forelimb anlage at stage 14 (Jacob
et al., 1978). These migrating somitic cells, which express root ganglia.
These data demonstrate that the wave of Pax-3- andthe transcription factors Pax-3 and Pax-7, have been shown
to emerge from the lateral part of the dermomyotome and Pax-7-positive muscle precursors migrating from early de-
velopmental stages on into the limb express FREK nearlyto migrate into the limb bud primordium, where they differ-
entiate and start expressing myogenic determination factors a day after the muscle progenitors have reached the limb
mesenchyme. Around 20 hr later, these muscle precursorssuch as MyoD and Myf-5 (Ordahl and Le Douarin, 1992;
Williams and Ordahl, 1994; Goulding et al., 1994; Bober et start expressing myogenic determination factors such as
MyoD. Since the expression of myogenic determinational., 1994). To better understand the potential role of FREK
during myoblast precursor migration to the limb, we have factors is diagnostic of the onset of terminal differentia-
tion, FREK is expressed in myoblasts prior to overt muscleexamined FREK expression in relation to that of MyoD,
Pax-3, and Pax-7. differentiation.
Near-adjacent sections of chick embryos were made at
the forelimb level of stage 18, 20, and 23 embryos which
then were hybridized with isotopic FREK, MyoD, Pax-3, DISCUSSION
and Pax-7 RNA probes. At stage 18, early limb muscle pre-
cursors, recognized by their Pax-3 and Pax-7 expression The aim of this study was to examine the early events
leading to the formation of the paraxial and limb bud skele-(Figs. 4C and 4D, respectively), do not express FREK or
MyoD (Figs. 4A and 4B, respectively). As described above, tal muscles, using the expression pattern of FREK, a new
avian ®broblast growth factor receptor, as an early markerFREK is faintly expressed in the lateral part of the dermomy-
otome and in the myotome, while MyoD expression is re- of proliferating myoblasts. We compared the distribution
pattern of FREK to those of Pax-3 and Pax-7, which havestricted to the myotome. By stage 20, FREK-positive cells
have appeared in the limb mesenchyme (Fig. 5A). Their been recently shown to be expressed by early muscle precur-
sors migrating into the limb bud, and to that of MyoD,distribution in the proximal limb bud mesenchyme is very
similar to that of Pax-3 and Pax-7 (Figs. 5C and 5D). At this which is expressed exclusively in terminally differentiating
muscle cells. This study reveals several important newstage of development, no MyoD expression is observed in
this region (Fig. 5B). By stage 23, all four genes are expressed ®ndings: (1) that FREK is expressed in most, if not all, repli-
cating myoblasts or their precursors, regardless of their de-in the limb bud. FREK is highly expressed in the ventral
and dorsal premuscle masses that begin to differentiate at velopmental stage (i.e., embryonic, fetal, or adult/satellite
cell myoblasts); (2) that FREK-positive myoblasts are ®rstthis stage of development (Fig. 6A). The domain of expres-
sion of FREK is similar to that of Pax-3 and Pax-7 (Figs. 6C observed in the lateral dermomyotome just before dermis
formation and that they appear to migrate into the myo-and 6D). This suggests either that Pax-3- and Pax-7-positive
cells that have migrated from the somite have now started tome as a second wave of muscle precursors, around 15 hr
after the ®rst wave of MyoD-positive, postmitotic myoto-to express FREK or, alternatively, that Pax-3, Pax-7, and
FREK are expressed by distinct cells. This latter possibility mal cells; and (3) that in the limb bud, migrating muscle
precursors expressing Pax-3 and Pax-7 reach the limb mes-would imply that expression of Pax-3 and Pax-7 in limb
muscle progenitors ceases prior to FREK expression. By enchyme, where they start expressing FREK and, only a day
later, the myogenic determination factor MyoD.comparison, the MyoD ®eld of expression (Fig. 6B) is re-
stricted compared to that of FREK (Fig. 6A) and Pax-7 (Fig.
6D) and, as reported earlier, to Pax-3 (Fig. 6C; Williams and FREK: A Marker for Skeletal Muscle MyoblastsOrdahl, 1994). As development proceeds, FREK expression
in all skeletal muscles of the body increases to reach a peak Based on their differing in vitro characteristics, the my-
oblasts isolated from developing embryonic and adult mus-at E9 (Marcelle et al., 1994). At E6, the last developmental
stage at which we compared FREK expression to MyoD, cles are divided into somitic, embryonic, fetal, and neona-
tal/satellite cell types (Cossu and Molinaro, 1987; reviewedPax-3, and Pax-7, prominent expression of FREK is observed
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in Miller, 1992). We have previously shown that the avian FREK. In vitro, FREK expression is up-regulated upon
addition of FGF2 to serum-starved satellite cells, con-®broblast growth factor FREK is expressed by satellite cells
isolated from posthatching chick embryo muscles (Marcelle comitant with their increased proliferation (Marcelle et
al., 1994; Halevy et al., 1994). These characteristics sug-et al., 1994; Halevy et al., 1994). Satellite cells are the only
myoblast-like cells in adult muscle, since they can undergo gest that FREK expression could maintain myoblasts in
a proliferative state. Although we have not shown in thisproliferation and terminal differentiation into myotubes.
Based on our analysis of FREK expression pattern during study that FREK is transcribed into an active protein
embryogenesis, we previously postulated that FREK could product, we believe that expression data presented above
be expressed by myoblasts during muscle development. The and elsewhere (Marcelle et al., 1994; Halevy et al., 1994)
experiments described in this paper have shown unequivo- suggest that FREK is a good candidate for mediating
cally that FREK is expressed from early stages onward in some of the in vivo and in vitro activities of FGF-like
mononucleated, replicating cells of the skeletal muscle lin- molecules on muscle myoblasts.
eage, properties which de®ne myoblasts. Therefore, we pro- Could FREK alone mediate myoblast proliferation
pose that FREK is expressed in a wide variety of myoblast and/or differentiation by FGFs? In vitro, FGFR1 has been
types of various origin (trunk, limb, and head) arising se- shown to regulate myoblast differentiation (Templeton
quentially during development such that it represents one and Hauschka, 1992). In vivo, FGFR1 does not seem to
of the earliest known molecular markers for this cell popu- be expressed in the early myotome (Orr-Urtreger et al.,
lation. 1991; Peters et al., 1992; Yamaguchi et al., 1992; our
observation): at early stages of development, FGFR1 dis-
plays a high level of expression throughout the mesen-
FGF Receptors and Their Ligands during Muscle chyme and the neural tube, suggesting that it is unlikely
Differentiation that FGFR1 plays a speci®c role during early myoblast
differentiation. Its high level of expression in mesenchy-There is a wealth of data describing the importance of
mal tissues could account for its faint expression re-FGF-like molecules for myoblast differentiation. While
ported in 10-day-old chick skeletal muscles (Patstone etnumerous studies have demonstrated that FGF promotes
al., 1993; our observation). In mouse, FGFR4 has beencontinuous cell proliferation and represses the onset of
shown to be expressed in the myotome, although it hasterminal differentiation, it also has been shown that
yet to be examined in myoblasts. Based on multiple dif-early myoblast precursors of the chick limb require FGF
ferences in sequence, structure, and expression betweenexposure in order to subsequently express their myo-
FREK and FGFR4, we have argued previously that thesegenic phenotype (Clegg et al., 1987; Olwin and
two FGF receptors are not the avian and mammalianHauschka, 1986; Templeton and Hauschka, 1992; Seed
homologues of the same molecule. They could neverthe-and Hauschka, 1988; reviewed in Pownall and Emerson,
less play similar (``homologous'') roles during skeletal1992). Therefore, under different in vitro experimental
muscle differentiation. An alternative possibility is thatprocedures, FGF can promote the proliferation or the dif-
FREK and an FGFR4-like molecule, perhaps togetherferentiation of myogenic precursors.
with other yet unidenti®ed FGF receptors, control vari-The expression of FREK during all stages of skeletal
ous aspects of muscle differentiation during avian em-muscle differentiation suggests an important role during
bryogenesis. Multiple FGF-like molecules are expressedmuscle differentiation. What could be the role of FREK
during skeletal muscle differentiation: FGF2, FGF4,during myoblast differentiation? We have shown in vivo
FGF6, and FGF7 are expressed in the developing myo-that FREK expression in the skeletal muscle reaches a
tome at early developmental stages, consistent with apeak at E9, which corresponds to the developmental
possible function as a ligand for FREK (Joseph-Silversteinstage at which myoblast proliferation is the most exten-
et al., 1989; Dono and Zeller, 1994; Savage et al., 1993;sive (Marcelle et al., 1994). FREK transcription then de-
Niswander and Martin, 1992; deLapeyriere et al., 1993;creases, along with muscle differentiation and fusion of
myoblasts into muscle ®bers, which do not express Han and Martin, 1993; Mason et al., 1994). Although we
FIG. 5. Expressions of FREK, MyoD, Pax-3, and Pax-7 at the forelimb level of a stage 20 chick embryo. Near-adjacent sections made at
the forelimb level were hybridized to FREK (A), MyoD (B), Pax-3 (C), and Pax-7 (D) isotopic RNA probes. FREK, Pax-3, and Pax-7 are
expressed in the limb muscle progenitors (arrowheads) while MyoD is exclusively expressed in the somitic myotome. NT, neural tube;
L, forelimb; D, dermomyotome; M, myotome. Images were obtained by superposing a pseudo bright-®eld image taken under uv light and
a dark-®eld image.
FIG. 6. Expressions of FREK, MyoD, Pax-3, and Pax-7 at the forelimb level of a stage 23 chick embryo. Dark-®eld images of near-adjacent
sections made at the forelimb level and hybridized to FREK (A), MyoD (B), Pax-3 (C), and Pax-7 (D) isotopic RNA probes. At that stage,
all four genes are expressed in the ventral and dorsal muscle masses of the limb. DRG, dorsal root ganglion; L, forelimb; M, myotome.
Images were obtained by superposing a pseudo bright-®eld image taken under uv light and a dark-®eld image.
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have shown previously that FGF2 can modulate FREK postmitotic myocytes are not continuously produced at
the cranial edge of the dermomyotome.expression in vitro (Marcelle et al., 1994; Halevy et al.,
1994), we cannot establish which of the FGF molecules
might activate the FREK signaling pathway during my-
Muscle Progenitors in the Limb Budoblast differentiation since we have not yet determined
the binding speci®cities of FREK to FGF2 or to other While muscle progenitors are present in the limb bud
FGF-like molecules. from stage 15 onward, we have shown in the present
study that FREK-positive cells are not detected in the
limb bud before stage 20. Interestingly, from stage 21
onward, cells of the limb bud are capable of forming mul-A Second Wave of Somitic Myoblasts
tinucleated muscle cells in vitro (Bonner and Hauschka,
It has been demonstrated in chick that muscle cells 1974), implying that muscle precursors present in the
originating from the dermomyotome ingress from the limb bud at stage 21 are determined for the muscle lin-
rostral edge of the dermomyotome to form the myotome. eage when challenged in an in vitro culture system. This
These myotomal cells (or myocytes) are differentiated, suggest that FREK expression by limb muscle precursors
mononucleated, and postmitotic (Kaehn et al., 1988). might represent a key event along their differentiation
They express myogenic determination factors (MyoD, pathway. This hypothesis is supported by the observa-
myogenin, etc.) as well as other muscle-speci®c proteins, tion mentioned above that muscle precursors present in
such as the embryonic form of the myosin heavy chain, a stage 23 chick limb require FGF to activate their mus-
the 13F4 antigen, and desmin (reviewed in Wachtler and cle differentiation pathway. Further studies will be
Christ, 1992; Ordahl, 1993). We have shown in this study needed to de®ne the importance of FREK expression for
that at around stage 17, cells expressing the avian FGF the differentiation of muscle precursors.
receptor FREK appear in the dermomyotome and in the In conclusion, we have examined the early events of
myotome; this is about 15 hr after the appearance of the myotome formation by using a probe for the recently
®rst myocytes. FREK-positive cells do not express the cloned avian FGF receptor FREK. The analysis of its pat-
muscle differentiation markers MF20 or 13F4 and they tern of expression during skeletal muscle development
are replicating. In addition, we have shown that FREK as well as its in vitro regulation during myoblast differ-
expression in the lateral portion of the dermomyotome entiation (Marcelle et al., 1994; Halevy et al., 1994; the
is distinct from that of MyoD, which is con®ned during present study) has suggested that FREK plays an im-
early stages of somite development to the medial lip of portant role during myoblast growth and differentiation.
the dermomyotome (Pownall and Emerson, 1992). Thus, Future experiments will be designed to determine the
it is likely that FREK-expressing cells represent a popula- exact function of FREK during this process by trying to
tion of cells distinct from the myotomal cells present in alter FREK expression during embryonic development.
the myotome prior to stage 17. The observation that the
myotomal cells present before this stage express MyoD
but did not express FREK suggests that FREK expression ACKNOWLEDGMENTS
is not a requirement during muscle differentiation. Nev-
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